Beta Blockers No Help in Advanced Prostate Cancer Findings question earlier retrospective data that pointed to possible survival benefit Dec 05, 2019
Docetaxel First May Boost Survival in mCRPC Superior outcomes observed versus approach where chemo follows newer agents Dec 05, 2019
Will Smith Vlogs His First Colonoscopy Actor hopes to bring awareness to important healthcare screening Dec 05, 2019
More Evidence That Aspirin Can Stave Off Death PLCO follow-up data support protective effect Dec 04, 2019
MRI-Guided Ultrasound Zaps Low-Risk Prostate Cancer TULSA devices achieves prostate volume reduction Dec 04, 2019
A Surgical First for Removal of an Appendiceal Neoplasm Technique deemed safe and feasible for selected patients and better than other minimally invasive approaches Nov 25, 2019
First-Line Combo Improves Survival in Advanced HCC Decreases in overall survival, progression-free survival hazards by almost 50% compared with sorafenib Nov 22, 2019
Study Suggests Viable Alternative to Mastectomy After In-Breast Recurrence Mastectomy rates low, good cancer control in selected patients Nov 21, 2019
Surgeon in Spotlight for Excising Soccer Ball-Sized Neck Tumor Called upon for expertise only 4 months into surgical career Nov 19, 2019
Metastatic Renal Cell Carcinoma: Watch for Brain Mets Present in roughly 5% of patients, survival worse in patients with larger or more lesions Nov 18, 2019
AHA Dedicates $20 Million to Youth Vaping Research Association and partners aim to "hold e-cigarette companies publicly accountable for their lies" Nov 16, 2019
Rheumatoid Arthritis Is No Bar to Cancer Immunotherapy Small study finds flares common with checkpoint inhibitors, but few patients stopped treatment because of them Nov 13, 2019
Results Mixed for At-Home HPV Testing Failed to show difference in clinical outcomes despite uptick in screening Nov 06, 2019
Why the Lower Risk of Prostate Cancer in Men With Diabetes? Findings from large cohort study do not support one leading hypothesis, researchers say Nov 06, 2019
Sex Assault at Mt. Sinai; Pharma's MD Millionaires; Mammography Marketing Machine This past week in healthcare investigations Oct 23, 2019
IGHV-Unmutated CLL: Gene Signature May Predict Outcomes After First-Line FCR Prognostic tool may predict who is likely to achieve a relatively long remission Oct 15, 2019
FCR Still an Option in IGHV-Unmutated CLL? Gene signature identifies lower-risk group with greater chemoimmunotherapy benefit Oct 08, 2019
First-Line Combo Boosts PFS in Untreated Bladder Cancer 'Clinically meaningful' trend in OS with atezolizumab-chemotherapy Oct 03, 2019
In Memory of Gerald Chodak, MD Pioneer of active surveillance for men with low-risk prostate cancer died last week Oct 03, 2019
New Standard in Third-Line Metastatic CRPC Cabazitaxel tops more anti-androgen in patients with "short-ish" response to abiraterone or enzalutamide Oct 01, 2019
Novel CDK 4/6 Inhibitor Fails in Triple Negative Breast Cancer Misses primary endpoints but has unexpected key benefit Oct 01, 2019
Neoadjuvant Anti-PD-1 Boosts pCR in TNBC Favorable trend toward improved event-free survival in preliminary analysis Sep 30, 2019
Trametinib Tx Shows Promise in Tough-to-Treat LGSOC Targeted drug provokes good response in chemoresistant, low-grade serous ovarian or peritoneal cancer Sep 30, 2019
Data Support 'Best Drug First' in EGFR-Mutant NSCLC Six-month survival gain with osimertinib, adding to PFS, safety advantages Sep 29, 2019
CDK 4/6 Inhibitors Boost OS in Advanced Breast Cancer Abemaciclib, ribociclib should become first-line treatment in HR-positive/HER2-negative disease, expert says Sep 29, 2019
PARP Inhibitors: The Key to a Tx Paradigm Shift in Ovarian Ca? PRIMA and VELIA trial findings advance niraparib and veliparib to the therapeutic front lines Sep 29, 2019
Abemaciclib Offers Hope in HR+/HER2+Breast Cancer Phase II monarcHER trial shows better PFS with abemaciclib-trastuzumab-fulvestrant Sep 29, 2019
First-Line Combo Boosts PFS in Advanced Ovarian Ca Olaparib-bevacizumab maintenance boosts PARP inhibitor benefits beyond BRCA-mutated subgroup Sep 28, 2019
Advanced HCC Trial Misses OS Endpoint But CheckMate 459 researchers tout "encouraging efficacy and favorable safety profile" Sep 28, 2019
Notable OS Gains with Dual Immunotherapy in Advanced NSCLC Secondary analysis of CheckMate 227 brings more good news for nivolumab-ipilimumab combo Sep 28, 2019
BCG Vax: A Shot Against Lung Cancer in Native Populations? 60-year follow-up data from a vaccine trial found surprising results Sep 25, 2019
Ibrutinib's Cardiotoxicity Comes Into Focus Study identifies new cardiac events linked to so-called targeted therapy Sep 25, 2019
How Often Does MRI Miss the Mark in Prostate Ca? Retrospective study finds 21% of patients with prostate cancer pathology did not have ROI on MRI Sep 25, 2019
Red Cell Distribution Width Strongly Predicts Hip Fracture Simple way to identify at-risk patients Sep 24, 2019
Wires or RFID Tags in Breast Cancer Excision? Women like the less obtrusive method, but small study doesn't quite settle question of whether there's a tradeoff Sep 24, 2019
ASTRO Unveils First RT Guideline for Pancreatic Cancer Radiation's role in pancreatic cancer is "controversial," says guideline author Sep 23, 2019
H. Pylori Found in Sleeve Gastrectomy Specimens Incidental findings can have important clinical implications in obese patients Sep 23, 2019
Tx Deintensification Wins in Head and Neck Cancer, But ... Only against another less-intensive approach in HPV-positive disease Sep 18, 2019